Amyloidosis classification: Difference between revisions
Jump to navigation
Jump to search
Line 14: | Line 14: | ||
|- | |- | ||
|AL | |AL | ||
|Light chains of immunoglobulines | |||
|Monoclonal gammopathy | |Monoclonal gammopathy | ||
|- | |- | ||
|AA | |AA | ||
|Serum amyloid A protein | |Serum amyloid A protein | ||
|Chronic | |Chronic inflammatory diseases | ||
|- | |- | ||
|AF | |AF | ||
Line 27: | Line 27: | ||
|ATTRwt | |ATTRwt | ||
|Wild-type transthyretin | |Wild-type transthyretin | ||
|Senile restrictive cardiomyopathy _ Transthyretin-related amyloidosis wild-type | |Senile restrictive cardiomyopathy _ Transthyretin-related amyloidosis wild-type | ||
|- | |- |
Revision as of 17:02, 9 May 2018
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amyloidosis classification On the Web |
American Roentgen Ray Society Images of Amyloidosis classification |
Risk calculators and risk factors for Amyloidosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Classification
Amyloidosis may be classified according to precursor amyloidogenic protein into different subtypes, include:
Abbreviation | Amyloidogenic protein | Clinical syndrome |
---|---|---|
AL | Light chains of immunoglobulines | Monoclonal gammopathy |
AA | Serum amyloid A protein | Chronic inflammatory diseases |
AF | Mutant transthyretin, A1-apolipoprotein, gelsolin, fibrinogen, etc. | Familial polyneuropathy/cardiomyopathy/nephropathy |
ATTRwt | Wild-type transthyretin | Senile restrictive cardiomyopathy _ Transthyretin-related amyloidosis wild-type |
AH | ß2-microglobulin | Dialysis-related amyloidosis |